Biological therapies in the acute respiratory distress syndrome

Bibliography

• Ashbaugh D, Boyd Bigelow D, Petty T, Levine B. Acute respiratory distress in Adults. Lancet 1967;290:319-23
   Google Scholar
• Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49
   PubMed Web of Science ®Google Scholar
• The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307:2526-33
   PubMed Web of Science ®Google Scholar
• Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 Years after acute respiratory distress syndrome. N Engl J Med 2011;364:1293-304
   PubMed Web of Science ®Google Scholar
• Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8
   PubMed Web of Science ®Google Scholar
• Papazian L, Forel J-M, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-16
   PubMed Web of Science ®Google Scholar
• Guérin C, Reignier J, Richard J-C, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159-68
   PubMed Web of Science ®Google Scholar
• Esteban A, Ferguson ND, Meade MO, et al. Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med 2008;177:170-7
   PubMed Web of Science ®Google Scholar
• Phua J, Badia JR, Adhikari NKJ, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009;179:220-7
   PubMed Web of Science ®Google Scholar
• Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003;31:S195-9
   PubMed Web of Science ®Google Scholar
• Frank JA, Wray CM, McAuley DF, et al. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2006;291:L1191-8
   PubMed Web of Science ®Google Scholar
• O’Kane CM, McKeown SW, Perkins GD, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med 2009;37:2242-9
   PubMed Web of Science ®Google Scholar
• Lanchou J, Corbel M, Tanguy M, et al. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003;31:536-42
   PubMed Web of Science ®Google Scholar
• Boyle AJ, Sweeney RM, McAuley DF. Pharmacological treatments in ARDS; a state-of-the-art update. BMC Med 2013;11:166
   PubMed Web of Science ®Google Scholar
• Allen TC, Kurdowska A. Interleukin 8 and acute lung injury. Arch Pathol Lab Med 2013;138:266-9
   PubMed Web of Science ®Google Scholar
• Donnelly SC, Haslett C, Strieter RM, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341:643-7
   PubMed Web of Science ®Google Scholar
• Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-32
   PubMed Web of Science ®Google Scholar
• Agrawal A, Zhuo H, Brady S, et al. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol 2012;303:L634-9
   PubMed Web of Science ®Google Scholar
• Kurdowska A, Miller EJ, Noble JM, et al. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 1996;157:2699-706
   PubMed Web of Science ®Google Scholar
• Fudala R, Krupa A, Matthay MA, et al. Anti-IL-8 autoantibody:IL-8 immune complexes suppress spontaneous apoptosis of neutrophils. Am J Physiol Lung Cell Mol Physiol 2007;293:L364-74
   PubMed Web of Science ®Google Scholar
• Allen TC, Fudala R, Nash SE, Kurdowska A. Anti–interleukin 8 Autoantibody:interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung. Arch Pathol Lab Med 2009;131:452-6
   Web of Science ®Google Scholar
• Fudala R, Krupa A, Stankowska D, et al. Anti-interleukin-8 autoantibody:interleukin-8 immune complexes in acute lung injury/acute respiratory distress syndrome. Clin Sci 2008;114:403
   PubMed Web of Science ®Google Scholar
• Krupa A, Kato H, Matthay MA, Kurdowska AK. Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004;286:L1105-13
   PubMed Web of Science ®Google Scholar
• Bao Z, Ye Q, Gong W, et al. Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int Immunopharmacol 2010;10:259-63
   PubMed Web of Science ®Google Scholar
• Leeper-Woodford SK, Carey PD, Byrne K, et al. Tumor necrosis factor alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury. Am Rev Respir Dis 1991;143:1076-82
   PubMed Web of Science ®Google Scholar
• Goncalves de Moraes VL, Boris Vargaftig B, Lefort J, et al. Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br J Pharmacol 1996;117:1792-6
   PubMed Web of Science ®Google Scholar
• Wilson MR, Goddard ME, O’Dea KP, et al. Differential roles of p55 and p75 tumor necrosis factor receptors on stretch-induced pulmonary edema in mice. Am J Physiol Lung Cell Mol Physiol 2007;293:L60-8
   PubMed Web of Science ®Google Scholar
• Parsons PE, Matthay MA, Ware LB, Eisner MD. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L426-31
   PubMed Web of Science ®Google Scholar
• Windsor AC, Walsh CJ, Mullen PG, et al. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 1993;91:1459-68
   PubMed Web of Science ®Google Scholar
• Imai Y, Kawano T, Iwamoto S, et al. Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits. J Appl Physiol 1999;87:510-15
   PubMed Web of Science ®Google Scholar
• Abraham E, Anzueto A, Gutierrez G, et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet 1998;351:929-33
   PubMed Web of Science ®Google Scholar
• Cohen J, Carlet J. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 1996;24:1431-40
   PubMed Web of Science ®Google Scholar
• Bertok S, Wilson MR, Morley PJ, et al. Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilator-induced lung injury. Thorax 2012;67:244-51
   PubMed Web of Science ®Google Scholar
• Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431
   PubMed Web of Science ®Google Scholar
• Schumann RR. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 1992;143:11-15
   PubMedGoogle Scholar
• Haziot A, Tsuberi BZ, Goyert SM. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 1993;150:5556-65
   PubMed Web of Science ®Google Scholar
• Martin TR, Rubenfeld GD, Ruzinski JT, et al. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:937-44
   PubMed Web of Science ®Google Scholar
• Tasaka S, Ishizaka A, Yamada W, et al. Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am J Respir Cell Mol Biol 2003;29:252-8
   PubMed Web of Science ®Google Scholar
• Dolinay T, Kim YS, Howrylak J, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 2012;185:1225-34
   PubMed Web of Science ®Google Scholar
• Pugin J, Ricou B, Steinberg KP, et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996;153:1850-6
   PubMed Web of Science ®Google Scholar
• Ganter MT, Roux J, Miyazawa B, et al. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin–dependent mechanisms. Circ Res 2008;102:804-12
   PubMed Web of Science ®Google Scholar
• Olman MA, White KE, Ware LB, et al. Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1beta-induced IL-6 expression. J Immunol 2004;172:2668-77
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-26
   PubMed Web of Science ®Google Scholar
• Kolliputi N, Shaik RS, Waxman AB. The inflammasome mediates hyperoxia-induced alveolar cell permeability. J Immunol 2010;184:5819-26
   PubMed Web of Science ®Google Scholar
• Fukumoto J, Fukumoto I, Parthasarathy PT, et al. NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am J Physiol Cell Physiol 2013;305:C182-9
   PubMed Web of Science ®Google Scholar
• Ferretti S, Bonneau O, Dubois GR, et al. IL-17, Produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003;170:2106-12
   PubMed Web of Science ®Google Scholar
• Griffin GK, Newton G, Tarrio ML, et al. IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 2012;188:6287-99
   PubMed Web of Science ®Google Scholar
• Banchereau J, Pascual V, O’Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012;13:925-31
   PubMed Web of Science ®Google Scholar
• Xu F, Liu Q, Lin S, et al. IL-27 is elevated in acute lung injury and mediates inflammation. J Clin Immunol 2013;33:1257-68
   PubMed Web of Science ®Google Scholar
• Thompson LF, Eltzschig HK, Ibla JC, et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004;200:1395-405
   PubMed Web of Science ®Google Scholar
• Eckle T, Füllbier L, Wehrmann M, et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007;178:8127-37
   PubMed Web of Science ®Google Scholar
• Sitkovsky MV, Lukashev D, Apasov S, et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004;22:657-82
   PubMed Web of Science ®Google Scholar
• Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001;414:916-20
   PubMed Web of Science ®Google Scholar
• Ehrentraut H, Clambey ET, McNamee EN, et al. CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J 2013;27:2207-19
   PubMed Web of Science ®Google Scholar
• Bellingan G, Maksimow M, Howell DC, et al. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. Lancet Respir Med 2014;2:98-107
   PubMed Web of Science ®Google Scholar
• Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme–related carboxypeptidase (ACE2) converts angiotensin 1 to angiotensin 1-9. Circ Res 2000;87:e1-9
   Google Scholar
• Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-8
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Penninger JM. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci 2007;64:2006-12
   PubMed Web of Science ®Google Scholar
• Adamzik M, Frey U, Sixt S, et al. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J 2007;29:482-8
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005;436:112-16
   PubMed Web of Science ®Google Scholar
• Treml B, Neu N, Kleinsasser A, et al. Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets. Crit Care Med 2010;38:596-601
   PubMed Web of Science ®Google Scholar
• López J, Martínez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 2002;221:1-92
   PubMed Web of Science ®Google Scholar
• Kangawa K, Kitamura K, Minamino N, et al. Adrenomedullin: a new hypotensive peptide. J Hypertens Suppl 1996;14:S105-10
   PubMedGoogle Scholar
• Kubo A, Minamino N, Isumi Y, et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 1998;273:16730-8
   PubMed Web of Science ®Google Scholar
• Ishizaka Y, Ishizaka Y, Tanaka M, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994;200:642-6
   PubMed Web of Science ®Google Scholar
• Hippenstiel S, Witzenrath M, Schmeck B, et al. Adrenomedullin reduces endothelial hyperpermeability. Circ Res 2002;91:618-25
   PubMed Web of Science ®Google Scholar
• Itoh T, Obata H, Murakami S, et al. Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 2007;293:L446-52
   PubMed Web of Science ®Google Scholar
• Müller HC, Witzenrath M, Tschernig T, et al. Adrenomedullin attenuates ventilator-induced lung injury in mice. Thorax 2010;65:1077-84
   PubMed Web of Science ®Google Scholar
• Idell S, Koenig KB, Fair DS, et al. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 1991;261:L240-8
   PubMed Web of Science ®Google Scholar
• Bastarache JA, Wang L, Geiser T, et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax 2007;62:608-16
   PubMed Web of Science ®Google Scholar
• Kambas K, Markiewski MM, Pneumatikos IA, et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J Immunol 2008;180:7368-75
   PubMed Web of Science ®Google Scholar
• Welty-Wolf KE, Carraway MS, Miller DL, et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001;164:1988-96
   PubMed Web of Science ®Google Scholar
• Vincent J-L, Artigas A, Petersen LC, Meyer C. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. Crit Care Med 2009;37:1874-80
   PubMed Web of Science ®Google Scholar
• Morris PE, Steingrub JS, Huang BY, et al. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm Med 2012;12:5
   PubMed Web of Science ®Google Scholar
• Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003;285:L514-21
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012;366:2055-64
   PubMed Web of Science ®Google Scholar
• Liu KD, Levitt J, Zhuo H, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008;178:618-23
   PubMed Web of Science ®Google Scholar
• Cornet AD, Hofstra JJ, Vlaar AP, et al. Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome. J Thromb Haemost 2013;11:894-901
   PubMed Web of Science ®Google Scholar
• Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731-40
   PubMed Web of Science ®Google Scholar
• Finch PW, Mark Cross LJ, McAuley DF, Farrell CL. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models. J Cell Mol Med 2013;17:1065-87
   PubMed Web of Science ®Google Scholar
• Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 2013;187:751-60
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002;282:L924-40
   PubMed Web of Science ®Google Scholar
• Panos RJ, Rubin JS, Csaky KG, et al. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest 1993;92:969-77
   PubMed Web of Science ®Google Scholar
• Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009;106:16357-62
   PubMed Web of Science ®Google Scholar
• Cross LJ, O’Kane CM, McDowell C, et al. Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol. Trials 2013;14:51
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39
   PubMed Web of Science ®Google Scholar
• Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1601-5
   PubMed Web of Science ®Google Scholar
• Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002;166:1332-7
   PubMed Web of Science ®Google Scholar
• Ware LB, Kaner RJ, Crystal RG, et al. VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema. Eur Respir J 2005;26:101-5
   PubMed Web of Science ®Google Scholar
• Perkins GD, Roberts J, McAuley DF, et al. Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury. Thorax 2005;60:153-8
   PubMed Web of Science ®Google Scholar
• Huffman Reed JA, Rice WR, Zsengellér ZK, et al. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol 1997;273:L715-25
   PubMed Web of Science ®Google Scholar
• Trapnell BC, Whitsett JA. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002;64:775
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Liles WC, Radella FI, et al. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 2000;28:1-7
   PubMed Web of Science ®Google Scholar
• Reed JAH, Rice WR, Zsengellér ZK, et al. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol Lung Cell Mol Physiol 1997;273:L715-25
   Web of Science ®Google Scholar
• Paine R, Wilcoxen SE, Morris SB, et al. Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury. Am J Pathol 2003;163:2397-406
   PubMed Web of Science ®Google Scholar
• Paine R, Standiford TJ, Dechert RE, et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012;40:90-7
   PubMed Web of Science ®Google Scholar
• Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007;8:173-84
   PubMed Web of Science ®Google Scholar
• Devaney J, Contreras M, Laffey JG. Clinical review: gene-based therapies for ALI/ARDS: where are we now? Crit Care 2011;15:224
   PubMed Web of Science ®Google Scholar
• Sakurai H, Kawabata K, Sakurai F, et al. Innate immune response induced by gene delivery vectors. Int J Pharm 2008;354:9-15
   PubMed Web of Science ®Google Scholar
• Lin X, Dean DA. Gene therapy for ALI/ARDS. Crit Care Clin 2011;27:705-18
   PubMed Web of Science ®Google Scholar
• Moss RB, Milla C, Colombo J, et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum Gene Ther 2007;18:726-32
   PubMed Web of Science ®Google Scholar
• McCarter SD, Mei SHJ, Lai PFH, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007;175:1014-26
   PubMed Web of Science ®Google Scholar
• Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol 2009;296:L713-25
   PubMed Web of Science ®Google Scholar
• Mutlu GM, Machado-Aranda D, Norton JE, et al. Electroporation-mediated gene transfer of the Na +, K + -ATPase rescues endotoxin-induced lung injury. Am J Respir Crit Care Med 2007;176:582-90
   PubMed Web of Science ®Google Scholar
• Lin E-H, Chang H-Y, Yeh S-D, et al. Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury. Nanomedicine 2013;9(8):1293-303
   PubMed Web of Science ®Google Scholar
• Hassett P, Curley GF, Contreras M, et al. Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury. Intensive Care Med 2011;37:1680-7
   PubMed Web of Science ®Google Scholar
• Ghannam S, Bouffi C, Djouad F, et al. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 2010;1:2
   PubMed Web of Science ®Google Scholar
• Hayes M, Curley G, Ansari B, Laffey JG. Clinical review: stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Crit Care 2012;16:205
   PubMed Web of Science ®Google Scholar
• Németh K, Leelahavanichkul A, Yuen PST, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2008;15:42-9
   PubMed Web of Science ®Google Scholar
• Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010;28:2229-38
   PubMed Web of Science ®Google Scholar
• Gupta N, Krasnodembskaya A, Kapetanaki M, et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax 2012;67:533-9
   PubMed Web of Science ®Google Scholar
• Krasnodembskaya A, Samarani G, Song Y, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol 2012;302:L1003-13
   PubMed Web of Science ®Google Scholar
• Curley GF, Hayes M, Ansari B, et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012;67:496-501
   PubMed Web of Science ®Google Scholar
• Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012;18:759-65
   PubMed Web of Science ®Google Scholar
• McAuley DF, Curley GF, Hamid UI, et al. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 2014; In press
   PubMed Web of Science ®Google Scholar
• Sweeney RM, McAuley DF. Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial? Thorax 2012;67:475-6
   PubMed Web of Science ®Google Scholar
• Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-93
   PubMed Web of Science ®Google Scholar
• Sheu C-C, Gong MN, Zhai R, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest 2010;138:559-67
   PubMed Web of Science ®Google Scholar
• Eisner MD, Thompson T, Hudson LD, et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:231-6
   PubMed Web of Science ®Google Scholar
• Calfee CS, Eisner MD, Ware LB, et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007;35:2243-50
   PubMed Web of Science ®Google Scholar
• Proudfoot AG, McAuley DF, Griffiths MJD, Hind M. Human models of acute lung injury. Dis Model Mech 2011;4:145-53
   PubMed Web of Science ®Google Scholar